HUGUES, B. et al. Interleukin-1/6 Blockade for the Treatment of Severe Steroid-Refractory BNT162b2 Vaccine-Induced Adult-Onset Still’s Disease. European Journal of Case Reports in Internal Medicine, v. 9, n. 8, 29 Aug.2022.